Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma

Aim: To evaluate optimal systemic therapy sequencing (first-line targeted therapy (1L-TT) vs. first-line immunotherapy (1L-IO)) in patients with BRAF-mutated metastatic melanoma. Methods: Nation-wide prospective data of patients with newly diagnosed BRAF-mutated metastatic melanoma were retrieved fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kartolo, Adi, Deluce, Jasna, Hopman, Wilma M., Liu, Linda, Baetz, Tara, Ernst, Scott, Lenehan, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947206/
https://www.ncbi.nlm.nih.gov/pubmed/35323326
http://dx.doi.org/10.3390/curroncol29030126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947206/
https://www.ncbi.nlm.nih.gov/pubmed/35323326
http://dx.doi.org/10.3390/curroncol29030126

Ejemplares similares